Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Oseltamivir treatment and prophylaxis in a neonatal intensive care unit during a 2009 H1N1 influenza outbreak.

Pannaraj PS, Tam B, Akan D.

J Perinatol. 2011 Jul;31(7):487-93. doi: 10.1038/jp.2010.159. Epub 2011 Jan 13.

PMID:
21233797
2.

Influenza A/H1N1/2009 outbreak in a neonatal intensive care unit.

Tsagris V, Nika A, Kyriakou D, Kapetanakis I, Harahousou E, Stripeli F, Maltezou H, Tsolia M.

J Hosp Infect. 2012 May;81(1):36-40. doi: 10.1016/j.jhin.2012.02.009. Epub 2012 Mar 30.

PMID:
22463979
3.

Swine influenza A (H1N1) virus infection in infants.

Zenciroglu A, Kundak AA, Aydin M, Okumus N, Dursun A, Ipek MS, Karagol BS, Hakan N, Karadag NN, Altas AB, Korukluoglu G.

Eur J Pediatr. 2011 Mar;170(3):333-8. doi: 10.1007/s00431-010-1293-5. Epub 2010 Sep 21.

PMID:
20857145
4.

Oseltamivir pharmacokinetics and clinical experience in neonates and infants during an outbreak of H1N1 influenza A virus infection in a neonatal intensive care unit.

Standing JF, Nika A, Tsagris V, Kapetanakis I, Maltezou HC, Kafetzis DA, Tsolia MN.

Antimicrob Agents Chemother. 2012 Jul;56(7):3833-40. doi: 10.1128/AAC.00290-12. Epub 2012 May 7.

5.

Oseltamivir dosing for influenza infection in premature neonates.

Acosta EP, Jester P, Gal P, Wimmer J, Wade J, Whitley RJ, Kimberlin DW; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

J Infect Dis. 2010 Aug 15;202(4):563-6. doi: 10.1086/654930.

6.

Oseltamivir use in low-birth weight infants during the 2009 nH1N1 influenza a outbreak in the Western Cape, South Africa.

Holgate SL, Bekker A, Rabie H, Cotton MF.

J Trop Pediatr. 2012 Apr;58(2):102-6. doi: 10.1093/tropej/fmr050. Epub 2011 Jun 7.

PMID:
21653546
7.

[Influenza A H1N1 in neonatal intensive care unit: analysis and lessons].

Leick-Courtois C, Haÿs S, Perpoint T, Basson E, Valette M, Lina B, Boibieux A, Picaud JC.

Arch Pediatr. 2011 Oct;18(10):1069-75. doi: 10.1016/j.arcped.2011.07.008. Epub 2011 Sep 15. French.

PMID:
21924878
8.

Triple-combination antiviral drug for pandemic H1N1 influenza virus infection in critically ill patients on mechanical ventilation.

Kim WY, Young Suh G, Huh JW, Kim SH, Kim MJ, Kim YS, Kim HR, Ryu YJ, Han MS, Ko YG, Chon GR, Lee KH, Choi SH, Hong SB; Korean Society of Critical Care Medicine H1N1 Collaborative.

Antimicrob Agents Chemother. 2011 Dec;55(12):5703-9. doi: 10.1128/AAC.05529-11. Epub 2011 Oct 3.

9.

Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009.

Lee VJ, Yap J, Tay JK, Barr I, Gao Q, Ho HJ, Tan BH, Kelly PM, Tambyah PA, Kelso A, Chen MI.

BMC Infect Dis. 2010 Jun 10;10:164. doi: 10.1186/1471-2334-10-164.

10.

Oseltamivir ring prophylaxis for containment of 2009 H1N1 influenza outbreaks.

Lee VJ, Yap J, Cook AR, Chen MI, Tay JK, Tan BH, Loh JP, Chew SW, Koh WH, Lin R, Cui L, Lee CW, Sung WK, Wong CW, Hibberd ML, Kang WL, Seet B, Tambyah PA.

N Engl J Med. 2010 Jun 10;362(23):2166-74. doi: 10.1056/NEJMoa0908482.

11.

Experience with oseltamivir in the control of a nursing home influenza B outbreak.

Parker R, Loewen N, Skowronski D.

Can Commun Dis Rep. 2001 Mar 1;27(5):37-40. English, French.

12.

Outbreak of antiviral drug-resistant influenza a in long-term care facility, Illinois, USA, 2008.

Dharan NJ, Patton M, Siston AM, Morita J, Ramirez E, Wallis TR, Deyde V, Gubareva LV, Klimov AI, Bresee JS, Fry AM.

Emerg Infect Dis. 2009 Dec;15(12):1973-6. doi: 10.3201/eid1512.081644.

13.

Pandemic influenza A(H1N1) 2009 virus outbreak among boarding school pupils in Madagascar: compliance and adverse effects of prophylactic oseltamivir treatment.

Rajatonirina S, Heraud JM, Randrianasolo L, Razanajatovo N, Ramandimbisoa T, Ratsitorahina M, Richard V.

J Infect Dev Ctries. 2011 Mar 21;5(3):156-62.

14.

Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v.

Petersen E, Keld DB, Ellermann-Eriksen S, Gubbels S, Ilkjær S, Jensen-Fangel S, Lindskov C.

Scand J Infect Dis. 2011 Jul;43(6-7):495-503. doi: 10.3109/00365548.2011.556144. Epub 2011 Feb 10.

PMID:
21309638
15.

Antiviral drugs in influenza: an adjunct to vaccination in some situations.

[No authors listed]

Prescrire Int. 2006 Feb;15(81):21-30.

PMID:
16548114
16.

Clinical features of hospitalised children with 2009 H1N1 influenza virus infection.

Calitri C, Gabiano C, Garazzino S, Pinon M, Zoppo M, Cuozzo M, Scolfaro C, Tovo PA.

Eur J Pediatr. 2010 Dec;169(12):1511-5. doi: 10.1007/s00431-010-1255-y. Epub 2010 Jul 22.

PMID:
20652313
17.

Efficacy and safety of oral oseltamivir for influenza prophylaxis in transplant recipients.

Ison MG, Szakaly P, Shapira MY, Kriván G, Nist A, Dutkowski R.

Antivir Ther. 2012;17(6):955-64. doi: 10.3851/IMP2192. Epub 2012 Jun 22.

PMID:
22728756
18.

Clinical and epidemiological characteristics of patients with influenza A (H1N1) 2009 attended to at the emergency room of a children's hospital.

Lera E, Wörner NT, Sancosmed M, Fàbregas A, Casquero A, Melendo S, Miserachs M, Tórtola T, Borrego A, Campins M, Moraga F, Figueras C, Cebrián R.

Eur J Pediatr. 2011 Mar;170(3):371-8. doi: 10.1007/s00431-011-1399-4. Epub 2011 Jan 28.

PMID:
21274563
19.

Safety and pharmacokinetics of oseltamivir for prophylaxis of neonates exposed to influenza H1N1.

Maltezou HC, Drakoulis N, Siahanidou T, Karalis V, Zervaki E, Dotsikas Y, Loukas YL, Theodoridou M.

Pediatr Infect Dis J. 2012 May;31(5):527-9. doi: 10.1097/INF.0b013e3182472f28.

PMID:
22209917
20.

Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Sep 11;58(35):969-72.

Items per page

Supplemental Content

Write to the Help Desk